PUNE, India, Nov. 25, 2015 /PRNewswire-iReach/ -- The Global
Veterinary Vaccines Market accounted for $5.3 billion in 2014 and is expected to grow at a
CAGR of 6.2% to reach $8.6 billion by
2022. The factors driving the veterinary vaccines market include
rising zoonotic diseases, growing incidence of animal diseases,
increasing investments by government and welfare associations.
However, factors such as increasing adoption of vegetarian food in
prominent economies and increasing costs of storage and maintenance
of vaccines are hindering the market growth. Growing awareness of
animal health in emerging economies and technological innovations
are likely to create opportunities for veterinary vaccines market
in the coming years.
(Photo - http://photos.prnewswire.com/prnh/20151125/290914)
Complete Report Details Available @
https://wiseguyreports.com/reports/veterinary-vaccines-global-market-outlook-trends-forecast-and-opportunity-assessment-2014-2022
.
The Global veterinary vaccines market is segmented on the basis
of diseases, technologies and geography. On the basis of diseases,
the veterinary vaccine market is segmented into companion animal
diseases (respiratory, gastrointestinal and reproductive tracts),
poultry diseases (bronchitis, avian influenza, newcastle disease
and marek's disease), porcine diseases (porcine reproductive
disease, swine pneumonia and swine influenza) and equine diseases
(rhinopneumonitis, influenza and encephalomyelitis). By
technologies, the market is categorized into toxoid vaccines, DNA
vaccines, recombinant vaccines, live attenuated vaccines (LAV) and
inactivated vaccines. By geography, it is segmented into
North America, Europe, Asia
Pacific and Rest of the World. European region is known to
be a leading veterinary vaccine market in terms of consumption,
closely followed by the U.S. However, Asia is expected to register a higher growth
rate during the forecast period owing to huge investment
opportunities in this region.
Some of the key players in the veterinary vaccine market include
Zoetis (U.S.), Merck Animal Health (U.S.), Merial Inc. (Sanofi)
(France), Elanco Animal Health
(U.S.)., Boehringer Ingelheim (Germany), Bayer Healthcare (Germany), Bioniche Animal Health (Canada), Heska Co. (U.S.), Ceva Animal Health,
Inc. and Virbac.
Request a sample Copy at
https://wiseguyreports.com/sample_request/veterinary-vaccines-global-market-outlook-trends-forecast-and-opportunity-assessment-2014-2022
.
This report offers:
- Market share assessments for the regional and country level
segments
- Market share analysis of the top industry players
- Strategic recommendations for the new entrants
- Market forecasts for a minimum of 8 years of all the mentioned
segments, sub segments and the regional markets
- Market Trends (Drivers, Constraints, Opportunities, Threats,
Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on
the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and
recent developments
- Supply chain trends mapping the latest technological
advancements
Make an enquiry before buying this Report at
https://wiseguyreports.com/enquiry/veterinary-vaccines-global-market-outlook-trends-forecast-and-opportunity-assessment-2014-2022
.
Table of Content
1 Executive Summary
2 Preface
2.1 Abstract
2.2 Research Scope
2.3 Research Methodology
2.4 Research Sources
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Veterinary Vaccines Market, By Diseases
5.1 Introduction
5.2 Companion animal diseases
5.2.1 Respiratory diseases
5.2.2 Gastrointestinal diseases
5.2.3 Reproductive diseases
5.3 Poultry diseases
5.3.1 Bronchitis
5.3.2 Avian influenza
5.3.3 Newcastle disease
5.3.4 Marek's disease
5.4 Porcine diseases
5.4.1 Porcine reproductive disease
5.4.2 Swine pneumonia
5.4.3 Swine influenza
5.5 Equine diseases
5.5.1 Rhinopneumonitis
5.5.2 Influenza
5.5.3 Encephalomyelitis
6 Global Veterinary Vaccines Market, By Technologies
6.1 Introduction
6.2 Toxoid vaccines
6.3 DNA vaccines
6.4 Recombinant vaccines
6.5 Live attenuated vaccines
6.6 Inactivated vaccines
7 Global Veterinary Vaccines Market, By Geography
7.1 North America
7.1.1 US
7.1.2 Canada
7.2 Europe
7.2.1 Germany
7.2.2 France
7.2.3 Italy
7.2.4 UK
7.2.5 Spain
7.3 Asia Pacific
7.3.1 Japan
7.3.2 China
7.3.3 India
7.3.4 Australia
7.3.5 New Zealand
7.3.6 Rest of Asia
7.4 Rest of the World
7.4.1 Latin America
7.4.2 Middle East
7.4.3 Africa
7.4.4 Others
8 Key Developments
8.1 Agreements, Partnerships, Collaborations and Joint
Ventures
8.2 Acquisitions & Mergers
8.3 New Product Launch
8.4 Expansions
8.5 Other Key Strategies
9 Company Profiling
9.1 Zoetis (U.S.)
9.2 Merck Animal Health (U.S.)
9.3 Merial Inc. (Sanofi) (France)
9.4 Elanco Animal Health (U.S.).
9.5 Boehringer Ingelheim (Germany)
9.6 Bayer Healthcare (Germany)
9.7 Bioniche Animal Health (Canada)
9.8 Heska Co. (U.S.)
9.9 Ceva Animal Health, Inc.
9.10 Virbac
Contact for More Information at sales@wiseguyreports.com
or +1 (646) 845 9349 (US) and +44 208 133 9349
(UK)
About Us
Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd.
and offers premium progressive statistical surveying, market
research reports, analysis & forecast data for industries and
governments around the globe. We also provide COTS (Commercial off
the Shelf) business sector reports as custom exploration agreeing
your particular needs.
Media Contact: Norah
Trent, WiseGuy Reports, +1 646 845 9349,
sales@wiseguyreports.com
News distributed by PR Newswire iReach:
https://ireach.prnewswire.com
SOURCE WiseGuy Reports